SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on February 9, 2012, reporting events occurring on February 7, 2012. The registrant is India Globalization Capital, Inc., a Maryland corporation. The filing addresses an "Other Event" (Item 8.01) regarding the company's iron ore operations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a press release rather than a financial statement.
Material Changes
The company announced an increment in its iron ore production capacity and estimated ore reserves. Specific quantitative details regarding the magnitude of these increases are contained in the attached press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K.
Guidance, Outlook, and Risks
Management commentary is limited to the issuance of a press release concerning operational capacity and reserves. The filing does not contain forward-looking guidance, risk factors, or disclosures of unusual items beyond the referenced operational update.
Investor Verification Checklist
- Verify the specific volume of the increase in iron ore production capacity.
- Confirm the updated estimated ore reserve figures.
- Review the full text of the press release attached as Exhibit 99.1 for operational details.
- Note the discrepancy between the company name in the metadata ("IGC Pharma, Inc.") and the registrant name in the filing ("India Globalization Capital, Inc.").